Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 901215, 5 pages
http://dx.doi.org/10.1155/2013/901215
Clinical Study

Increased Risk of Atrial and Ventricular Arrhythmia in Long-Lasting Psoriasis Patients

1Cardiology Department, Faculty of Medicine, Yuzunci Yil University, 65200 Van, Turkey
2Van High Edücation and Research Hospital, 65100 Van, Turkey
3Dermatology Department, Faculty of Medicine, Yuzunci Yil University, 65200 Van, Turkey
4Cardiology Department, Hisar Intercontinental Hospital, 34768 Istanbul, Turkey

Received 25 January 2013; Accepted 3 March 2013

Academic Editors: C. Carbucicchio, H. Kitabata, A. N. Makaryus, C. Spaulding, and G. Stabile

Copyright © 2013 Hakki Simsek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. M. Farber and M. L. Nall, “The natural history of psoriasis in 5,600 patients,” Dermatologica, vol. 148, no. 1, pp. 1–18, 1974. View at Google Scholar · View at Scopus
  2. L. Torok, E. Toth, and A. Bruncsak, “Correlation between psoriasis and cardiovascular diseases,” Zeitschrift fur Hautkrankheiten, vol. 57, no. 10, pp. 734–739, 1982. View at Google Scholar · View at Scopus
  3. T. Henseler and E. Christophers, “Disease concomitance in psoriasis,” Journal of the American Academy of Dermatology, vol. 32, no. 6, pp. 982–986, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Moya, M. Sanchez, M. D. Morales, and E. Brito, “Mitral valve prolapse (MVP) in psoriatic arthritis (PA),” Archives of Internal Medicine, vol. 147, no. 5, p. 992, 1987. View at Google Scholar · View at Scopus
  5. W. F. Muna, D. H. Roller, J. Craft, R. K. Shaw, and A. M. Ross, “Psoriatic arthritis and aortic regurgitation,” Journal of the American Medical Association, vol. 244, no. 4, pp. 363–365, 1980. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Chodorowska, D. Wojnowska, and M. Juszkiewicz-Borowiec, “C-reactive protein and α2-macroglobulin plasma activity in medium-severe and severe psoriasis,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 2, pp. 180–183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. G. Krueger and A. Bowcock, “Psoriasis pathophysiology: current concepts of pathogenesis,” Annals of the Rheumatic Diseases, vol. 64, no. 2, pp. ii30–ii36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. V. E. Friedewald Jr., J. C. Cather, K. B. Gordon, A. Kavanaugh, P. M. Ridker, and W. C. Roberts, “The editor's roundtable: psoriasis, inflammation, and coronary artery disease,” The American Journal of Cardiology, vol. 101, no. 8, pp. 1119–1126, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. H. M. Kremers, M. T. McEvoy, F. J. Dann, and S. E. Gabriel, “Heart disease in psoriasis,” Journal of the American Academy of Dermatology, vol. 57, no. 2, pp. 347–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. P. E. Dilaveris, E. J. Gialafos, G. K. Andrikopoulos et al., “Clinical and electrocardiographic predictors of recurrent atrial fibrillation,” Pacing and Clinical Electrophysiology, vol. 23, no. 3, pp. 352–358, 2000. View at Google Scholar · View at Scopus
  11. P. E. Dilaveris, E. J. Gialafos, S. K. Sideris et al., “Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation,” The American Heart Journal, vol. 135, no. 5 I, pp. 733–738, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Ozer, K. Aytemir, E. Atalar et al., “P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation,” Pacing and Clinical Electrophysiology, vol. 23, no. 11, pp. 1109–1112, 2000. View at Google Scholar · View at Scopus
  13. T. Liu and G. Li, “Is atrial fibrillation an inflammatory disease?” Medical Hypotheses, vol. 64, pp. 1237–1238, 2005. View at Google Scholar
  14. T. Liu, G. Li, L. Li, and P. Korantzopoulos, “Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis,” Journal of the American College of Cardiology, vol. 49, no. 15, pp. 1642–1648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Korantzopoulos, T. M. Kolettis, D. Galaris, and J. A. Goudevenos, “The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation,” International Journal of Cardiology, vol. 115, no. 2, pp. 135–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Kautzner and M. Malik, “QT interval dispersion and its clinical utility,” Pacing and Clinical Electrophysiology, vol. 20, no. 10, pp. 2625–2640, 1997. View at Google Scholar · View at Scopus
  17. M. Zabel, S. Portnoy, and M. R. Franz, “Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study,” Journal of the American College of Cardiology, vol. 25, no. 3, pp. 746–752, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kowalewski, M. Urban, B. Mroczko, and M. Szmitkowski, “Proinflammatory cytokines (IL-6, TNF-alpha) and cardiac troponin I (cTnI) in serum of young people with ventricular arrhythmias,” Polskie Archiwum Medycyny Wewnetrznej, vol. 108, no. 1, pp. 647–651, 2002. View at Google Scholar · View at Scopus
  19. A. B. Kimball, D. Robinson, Y. Wu et al., “Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002,” Dermatology, vol. 217, no. 1, pp. 27–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Neimann, D. B. Shin, X. Wang, D. J. Margolis, A. B. Troxel, and J. M. Gelfand, “Prevalence of cardiovascular risk factors in patients with psoriasis,” Journal of the American Academy of Dermatology, vol. 55, no. 5, pp. 829–835, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Shapiro, A. D. Cohen, M. David et al., “The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study,” Journal of the American Academy of Dermatology, vol. 56, no. 4, pp. 629–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. B. Kimball, C. Jacobson, S. Weiss, M. G. Vreeland, and Y. Wu, “The psychosocial burden of psoriasis,” The American Journal of Clinical Dermatology, vol. 6, no. 6, pp. 383–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. M. Klein, E. G. Vester, M. U. Brehm et al., “Inflammation of the myocardium as a trigger for arrhythmias,” Zeitschrift fur Kardiologie, vol. 89, no. 3, pp. III24–III35, 2000. View at Google Scholar · View at Scopus
  24. A. Sajadieha, O. W. Nielsen, V. Rasmussen, H. O. Hein, S. Abedini, and J. F. Hansen, “Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease,” European Heart Journal, vol. 25, no. 5, pp. 363–370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. O. Turgut, I. Tandogan, M. B. Yilmaz, K. Yalta, and O. Aydin, “Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease,” International Journal of Cardiology, vol. 144, no. 2, pp. 322–324, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. P. E. Dilaveris and C. I. Stefanadis, “P wave dispersion. A valuable non-invasive marker of vulnerability to atrial arrhythmias,” Hospital Chronicles, vol. 1, pp. 130–137, 2006. View at Google Scholar
  27. A. Michelucci, G. Bagliani, A. Colella et al., “P wave assessment: state of the art update,” Cardiac Electrophysiology Review, vol. 6, no. 3, pp. 215–220, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Yavuzkir, A. Ozturk, N. Dagli et al., “Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion,” Journal of International Medical Research, vol. 35, no. 6, pp. 796–802, 2007. View at Google Scholar · View at Scopus
  29. O. Dogdu, M. Yarlioglues, M. G. Kaya et al., “Assessment of atrial conduction time in patients with systemic lupus erythematosus,” Journal of Investigative Medicine, vol. 59, no. 2, pp. 281–286, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sgreccia, S. Morelli, L. Ferrante et al., “QT interval and QT dispersion in systemic sclerosis (scleroderma),” Journal of Internal Medicine, vol. 243, no. 2, pp. 127–132, 1998. View at Google Scholar · View at Scopus
  31. A. Cindas, Y. Gökçe-Kutsal, L. Tokgözoglu, and A. Karanfil, “QT dispersion and cardiac involvement in patients with rheumatoid arthritis,” Scandinavian Journal of Rheumatology, vol. 31, no. 1, pp. 22–26, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Schmitt and G. Wozel, “The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis,” Dermatology, vol. 210, no. 3, pp. 179–181, 2005. View at Google Scholar · View at Scopus
  33. H. Gunduz, E. Binak, H. Arinc et al., “The relationship between P wave dispersion and diastolic dysfunction,” Texas Heart Institute Journal, vol. 32, no. 2, pp. 163–167, 2005. View at Google Scholar · View at Scopus
  34. H. Gunduz, R. Akdemir, E. Binak, A. Tamer, and C. Uyan, “Relation between stage of left ventricular diastolic dysfunction and QT dispersion,” Acta Cardiologica, vol. 58, no. 4, pp. 303–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Saricaoglu, S. Gullulu, E. Bulbul, J. Cordan, and S. Tunali, “Echocardiographic findings in subjects with psoriatic arthropathy,” Journal of the European Academy of Dermatology and Venereology, vol. 17, no. 4, pp. 414–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. N. Cheema, M. W. Ahmed, A. H. Kadish, and J. J. Goldberger, “Effects of autonomic stimulation and blockade on signal-averaged P wave duration,” Journal of the American College of Cardiology, vol. 26, no. 2, pp. 497–502, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Marfella, P. Gualdiero, M. Siniscalchi et al., “Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients,” Hypertension, vol. 41, no. 2, pp. 237–243, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Mastrolonardo, A. Picardi, D. Alicino, A. Bellomo, and P. Pasquini, “Cardiovascular reactivity to experimental stress in psoriasis: a controlled investigation,” Acta Dermato-Venereologica, vol. 86, no. 4, pp. 340–344, 2006. View at Publisher · View at Google Scholar · View at Scopus